-
-
-
-
-
-
-
Tiziana Life Sciences Initiates Program to Develop Intranasal Foralumab in Type 1 Diabetes
-
-
-
-
-
-
-
Tiziana Life Sciences (TLSA) Announces 80K Insider Buy by Executive Chairman
-
-
-
-
-
-
-
Tiziana Life Sciences Announces Purchase of Common Shares by Executive Chairman
-
-
-
-
-
-
-
Tiziana Life Sciences PLC (“Tiziana” or “the Company”) - Publication of Prospectus
-
-
-
-
-
-
-
Tiziana Announces Closing of Offering and Resulting Total Voting Rights
-
-
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

